Melanoma vaccine trials begin at six centers for 200 patients
Marc Wallack of Mount Sinai Medical Center announces a three year double blind trial testing a melanoma vaccine to prevent recurrence. The study enrolls at least 200 patients whose tumors were recently removed and nodes invaded.
MENTIONED IN THIS ARTICLE
Marc Wallach
Chcarman
Mount Sinai Medical Center
Wallach
Also Mentioned on This Page
Wallack
Walkich’s
University of Florida, Duke
SUN
Midway Mall
Sun Feenhene
Tudor Rose
Avantia
Great Northern Mall
Thedar
Titan
Broad St. Elyria
Ohio
Valspar
Central Trust
Central Trust Office
Central Trust Company
FDIC